eMedTV Articles A-Z
The earliest that a generic Proventil HFA could become available is in 2010. This eMedTV article discusses the availability of generic traditional inhalers and programs in place to help those who cannot afford the new, more expensive inhalers.
At this time, no generic Provigil products are available on the market. This eMedTV Web page explains when a generic version of the drug may be available and discusses the potential dangers of buying so-called "generic Provigil" before this occurs.
Prozac is an antidepressant that is currently available as a generic. This section of the eMedTV site describes generic Prozac capsules, tablets, and liquid in more detail and lists the various strengths that are available for each form.
Right now, generic Pulmozyme is not available and, as this eMedTV page explains, may never be available if the laws surrounding biopharmaceuticals are not changed. This page also explains what biologic drugs are and the laws that pertain to them.
There are two generic Questran medicines available: Cholestyramine powder and Cholestyramine Light powder. This eMedTV article contains information on the manufacturer of these products and lists the strengths that are available.
This portion of the eMedTV archives offers a general overview of generic quinapril, which is sold under the name Quinapril tablets. Generic quinapril is manufactured by several companies and is available in a number of strengths.
There are currently no generic Qvar inhalers available on the market. This eMedTV resource explains when a generic version of Qvar is expected to become available and discusses the difference between a "generic name" of a drug and its generic version.
Generic ramelteon will not be available until at least 2017, when ramelteon's current patent expires. This eMedTV page provides more details about the drug's patent and explains the difference between a generic name and a generic version of a drug.
Generic ranitidine is available in over-the-counter and prescription strengths. This eMedTV Web page explains which forms of ranitidine are available as generics and discusses why generic forms of Zantac EFFERdose tablets and syrup are not available.
Razadyne is not yet available in generic form. This eMedTV article explains when generic Razadyne products could become available and discusses the potential dangers of buying so-called "generic Razadyne" before an approved version is available.
There are currently laws that prevent generic Rebif (interferon beta-1a) from being manufactured. This eMedTV page explains why generic Rebif products are not allowed to be made at this time and explores whether these laws will change in the future.
Generic Reclast is currently not available. This eMedTV resource explains why, describes what must happen for a generic version to become available, and also explains the difference between active ingredients in drugs and their generic names.
This eMedTV page covers generic Relafen, which is sold under the name Nabumetone tablets. This page lists some of generic Relafen's available strengths, which include 500 mg tablets and 750 mg tablets, and a few companies that manufacture the drug.
At this time, there are no generic Relenza (zanamivir) products licensed for sale. This page from the eMedTV Web site offers information on when a generic version may become available and explains the difference between Relenza and zanamivir.
A patent prevents any generic Relpax from being made in the U.S. This eMedTV resource explains that the earliest a generic Relpax could become available is in 2013. In the meantime, you should not buy any "generic Relpax" sold in other countries.
This eMedTV page provides a detailed discussion on generic Remeron, including the available strengths and forms. This page also explains that its "AB" rating from the FDA means that the generic form is considered equivalent to the brand-name version.
This eMedTV Web page explains why there may never be a generic Remicade available. This page also warns that any place claiming to sell a generic version of the drug is selling a product that is fake, substandard, and potentially dangerous.
Rescriptor is not yet available in generic form. The drug, as this eMedTV page explains, is currently protected by a patent that prevents any generic versions from being made. When the patent expires in 2013, generic Rescriptor may be available.
Generic Restoril is currently made by several companies and is available in two different strengths. This eMedTV segment provides an overview of the drug, including information on how the generic version compares to the brand-name version.
Generic Retrovir products are available in various forms, including capsules, tablets, and syrup. This eMedTV article lists the strengths available for generic Retrovir drugs and explains whether these products are equivalent to brand-name Retrovir.
Reyataz will not be available in generic form until April 2017 at the earliest. This part of the eMedTV archives discusses when a generic version may be available and explains why it may be dangerous to buy so-called "generic Reyataz" products.
As soon as the patent for Rhinocort Aqua expires in 2017, generic versions of the drug may be available. This eMedTV article describes generic Rhinocort Aqua in more detail and further explains when it may become available on the market.
One company has the exclusive rights to market brand-name Risperdal until at least 2011. This eMedTV page gives an overview of generic Risperdal and discusses the factors that could delay the introduction of a generic version of the drug.
T